48,833
edits
Line 506: | Line 506: | ||
*Defined by the presence of a fusion gene form with TFE3 @ Xp11.2. | *Defined by the presence of a fusion gene form with TFE3 @ Xp11.2. | ||
*TFE3 is the gene involved in the translocation seen in [[alveolar soft part sarcoma]] (ASPS). | *TFE3 is the gene involved in the translocation seen in [[alveolar soft part sarcoma]] (ASPS). | ||
*Poor prognosis ~ 50% present at stage IV, majority of lymph node metastases. | |||
*~1/3 of childhood RCC.<ref name=pmid17667536>{{Cite journal | last1 = Argani | first1 = P. | last2 = Olgac | first2 = S. | last3 = Tickoo | first3 = SK. | last4 = Goldfischer | first4 = M. | last5 = Moch | first5 = H. | last6 = Chan | first6 = DY. | last7 = Eble | first7 = JN. | last8 = Bonsib | first8 = SM. | last9 = Jimeno | first9 = M. | title = Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. | journal = Am J Surg Pathol | volume = 31 | issue = 8 | pages = 1149-60 | month = Aug | year = 2007 | doi = 10.1097/PAS.0b013e318031ffff | PMID = 17667536 }}</ref> | |||
===Microscopic=== | ===Microscopic=== |
edits